CVE-2014-2589

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in the Dashboard Backend service (stats/dashboard.jsp) in SonicWall Network Security Appliance (NSA) 2400 allows remote attackers to inject arbitrary web script or HTML via the sn parameter.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.98% Top 25%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securitytracker.com/id/1029884 third party advisory vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/91766 vdb entry
http://www.securityfocus.com/archive/1/531364/100/0/threaded mailing list third party advisory vdb entry
http://secunia.com/advisories/57275 third party advisory vendor advisory
http://www.securityfocus.com/bid/66042 third party advisory vdb entry exploit
http://www.vulnerability-lab.com/get_content.php?id=1100 third party advisory exploit
http://www.osvdb.org/104089 vdb entry broken link

Frequently Asked Questions

What is the severity of CVE-2014-2589?
CVE-2014-2589 has been scored as a medium severity vulnerability.
How to fix CVE-2014-2589?
To fix CVE-2014-2589, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-2589 being actively exploited in the wild?
It is possible that CVE-2014-2589 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.